Viewing nowSitacan Tablet 50 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 202005487 · Approved 2020.07.29 · Insurance code 653405170
Improvement of blood sugar control in type 2 diabetes
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It may be administered alone in the initial stages of treatment along with dietary and exercise regimens. If blood sugar control is difficult with monotherapy, it can be used in combination with metformin. Additionally, this medication can be used in conjunction with sulfonylureas, metformin, thiazolidinediones, or insulin if blood sugar control is inadequate with these sole therapies. By adding this medication among various combination therapies where effectiveness is insufficient, blood sugar control can be improved. Therefore, this medication is very effective for the treatment of type 2 diabetes.
This medication is administered once daily at a dose of 100 mg, whether as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. It can be taken regardless of meals. For patients with renal impairment, dosage adjustments are necessary depending on their kidney function. - Mild (glomerular filtration rate eGFR ≥ 60 and < 90 mL/min/1.73 m2): No dosage adjustment necessary. - Moderate (glomerular filtration rate eGFR ≥ 45 and < 60 mL/min/1.73 m2): Dosage adjustment required.
This medication may cause serious allergic reactions in some patients, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, immediately discontinue use and consult a healthcare professional. This medication can induce a condition called pancreatitis, which is inflammation of the pancreas; therefore, if symptoms like abdominal pain, nausea, or vomiting occur, immediate medical attention is required. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be given to patients with allergies to its components. Patients with impaired renal function must adjust the dosage of this medication; regular kidney function tests should be performed and it's essential to take this medication as directed by a healthcare professional. While taking this medication, symptoms of hypoglycemia may occur, so blood sugar levels should be closely monitored, especially when used with insulin or sulfonylurea drugs. If severe joint pain or blistering skin symptoms appear, immediately discontinue use and consult a healthcare professional. Use of this medication during pregnancy or breastfeeding is not recommended, and safety and efficacy have not been established for children and adolescents under 18 years of age. Elderly patients may have reduced kidney function, so it is important to regularly assess kidney function before and after taking this medication. In the event of overdose, general emergency measures should be taken, and blood dialysis may be necessary to remove the medication. No significant interactions have been reported with this medication when taken with other specific drugs; however, caution is needed with medications such as digoxin, so it is crucial to inform the healthcare professional about all medications being taken. If any abnormal symptoms occur while taking this medication, it is vital to consult a healthcare professional immediately to receive appropriate measures.
Severe hypersensitivity reactions (anaphylaxis, angioedema, urticaria), severe skin reactions (Stevens-Johnson syndrome, rash, blistering dermatitis), acute pancreatitis, acute renal failure, severe edema (peripheral edema), severe and disabling arthralgia, rhabdomyolysis, jaundice, severe neurological symptoms (cardiac arrest), pneumonia, diabetes complications, metabolic acidosis, cardiac arrest
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed, airtight container and kept at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication for a longer period.
Pale yellow-pink, round, biconvex film-coated tablet
30 tablets/PTP [10 tablets/PTP X3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.